Brenntag (FRA:BNR) has been given a €62.00 ($72.09) target price by stock analysts at Baader Bank in a research report issued on Wednesday. The firm presently has a “buy” rating on the stock. Baader Bank’s price objective would indicate a potential upside of 38.70% from the stock’s previous close.
BNR has been the subject of a number of other reports. Goldman Sachs Group set a €58.00 ($67.44) target price on Brenntag and gave the stock a “neutral” rating in a report on Wednesday. Commerzbank set a €61.00 ($70.93) price objective on Brenntag and gave the company a “buy” rating in a research note on Wednesday. UBS Group set a €50.00 ($58.14) price objective on Brenntag and gave the company a “neutral” rating in a research note on Monday, August 20th. Hauck & Aufhaeuser set a €62.00 ($72.09) price objective on Brenntag and gave the company a “buy” rating in a research note on Tuesday, July 24th. Finally, Kepler Capital Markets set a €63.00 ($73.26) price objective on Brenntag and gave the company a “buy” rating in a research note on Wednesday. One analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have issued a buy rating to the stock. Brenntag presently has a consensus rating of “Buy” and a consensus price target of €58.49 ($68.01).
Shares of BNR stock opened at €44.70 ($51.98) on Wednesday. Brenntag has a fifty-two week low of €43.06 ($50.07) and a fifty-two week high of €56.25 ($65.41).
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.